BIOMAT Database Logo BIOMAT Database Logo

Synthetic nucleosides and nucleotides. XVI. Synthesis and biological evaluations of a series of 1-beta-D-arabinofuranosylcytosine 5'-alkyl or arylphosphates. 1980

M Saneyoshi, and M Morozumi, and K Kodama, and H Machida, and A Kuninaka, and H Yoshino

UI MeSH Term Description Entries
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

M Saneyoshi, and M Morozumi, and K Kodama, and H Machida, and A Kuninaka, and H Yoshino
Synthetic nucleosides and nucleotides. XXXV. Synthesis and biological evaluations of 5-fluoropyrimidine nucleosides and nucleotides of 3-deoxy-beta-D-ribofuranose and related compounds.
November 1995, Chemical & pharmaceutical bulletin,
M Saneyoshi, and M Morozumi, and K Kodama, and H Machida, and A Kuninaka, and H Yoshino
Synthetic nucleosides and nucleotides. XXI. On the synthesis and biological evaluations of 2'-deoxy-alpha-D-ribofuranosyl nucleosides and nucleotides.
April 1984, Chemical & pharmaceutical bulletin,
M Saneyoshi, and M Morozumi, and K Kodama, and H Machida, and A Kuninaka, and H Yoshino
Nucleosides. XLVII. Synthesis of some N4-substituted derivarives of 1-beta-D-arabinofuranosylcytosine and -5-fluorocytosine.
January 1968, Journal of medicinal chemistry,
M Saneyoshi, and M Morozumi, and K Kodama, and H Machida, and A Kuninaka, and H Yoshino
Reactions of 2-acyloxyisobutyryl halides with nucleosides. Synthesis and biological evaluation of some 3"-acyl and 3',5'-diacyl derivatives of 1-beta-D-arabinofuranosylcytosine.
May 1976, Journal of medicinal chemistry,
M Saneyoshi, and M Morozumi, and K Kodama, and H Machida, and A Kuninaka, and H Yoshino
Synthetic nucleosides and nucleotides. XVIII. Synthesis and cytostatic activity of 5-fluoropyrimidine nucleosides of 3-amino-3-deoxy-beta-D-ribofuranose and related compounds.
October 1981, Chemical & pharmaceutical bulletin,
M Saneyoshi, and M Morozumi, and K Kodama, and H Machida, and A Kuninaka, and H Yoshino
A new synthesis of 5'-deoxy-8,5'-cyclo-adenosine and -inosine: conformationally-fixed purine nucleosides (nucleosides and nucleotides. XVI).
December 1976, Nucleic acids research,
M Saneyoshi, and M Morozumi, and K Kodama, and H Machida, and A Kuninaka, and H Yoshino
The synthesis, characterization, and preliminary biological evaluation of 1-beta-D-arabinofuranosylcytosine-5'-diphosphate-L-1,2-dipalmitin.
November 1978, Biochemical and biophysical research communications,
M Saneyoshi, and M Morozumi, and K Kodama, and H Machida, and A Kuninaka, and H Yoshino
Antiviral properties of nucleosides structurally related to 1-beta-d-arabinofuranosylcytosine.
January 1967, Antimicrobial agents and chemotherapy,
M Saneyoshi, and M Morozumi, and K Kodama, and H Machida, and A Kuninaka, and H Yoshino
Synthetic nucleosides and nucleotides. XXVIII. Synthesis of 5-alkylcytidines from 5-alkylbarbituric acids.
July 1988, Chemical & pharmaceutical bulletin,
M Saneyoshi, and M Morozumi, and K Kodama, and H Machida, and A Kuninaka, and H Yoshino
An efficient synthesis of 1-beta-D-arabinofuranosylcytosine.
May 1976, The Journal of organic chemistry,
Copied contents to your clipboard!